Upcoming Webinars

Antimicrobial resistance (AMR) is one of the most serious health threats of the 21st century, with a prediction of 10 million excess deaths each year globally by 2050, exceeding deaths caused by ca

Selecting the ideal dressings that work for you, your patients, and your patients’ wounds can be overwhelming.

The speakers will explore the importance of product selection when it comes to wound cleansing and achieving a balance and understanding the relationship between efficacy and cytotoxicity.

Lower extremity wounds, such as diabetic foot ulcers and venous ulcers, are more prone to issues of chronicity and recurrence as a result of factors such as peripheral arterial disease, diabetes, a

The recent demands placed on the health care system demonstrate the necessity of reducing wound complications and improving the healing trajectory of wounds.

Alginate or other gelling fiber dressings are defined for reimbursement purposes as "absorbent dressings that manage moderately- to highly-exudative full-thickness wounds" and "are composed of a mu

Join Prof. David Armstrong and Lee C.

Documenting a wound assessment is a critical part of wound care.

The management of tracheostomies is challenging and requires constant daily care to prevent skin breakdown.

Biofilm is present in chronic wounds anywhere from 60% to 100% of the time. Biofilm has multiple colony defenses that must be overcome to manage chronic wounds effectively. This webinar will discuss the role of treatment modalities in the effective management of biofilm, as well as clinical presentation of wounds in discontinuing intervention as control of the wound (less exudate, less slough, etc.) is obtained.

In this Product Navigator, Dr. Michael Desvigne explains the benefits he sees when using Vashe Wound Solution (pure hypochlorous acid) as a standard treatment for non-intact skin in the hospital.

Negative Pressure Wound Therapy (NPWT) is a widely accepted modality in the treatment of complex wounds.

Explore the wound healing process with a look into the benefits added by placental tissue.

According to statistical data, more than 2.5 million patients will be impacted by pressure injuries in the United States alone per year, with estimated care for these wounds averaging around $11 mi

Hospital-acquired pressure injuries (HAPIs) continue to rise despite progress made in reducing all other hospital-acquired conditions (HACs).

Despite new wound care products and technologies, the burden of wounds for both patients and their providers continues to rise. In this environment, wound biofilm continues to emerge as a key factor in the pathology of non-healing wounds of all etiologies, and effective biofilm management as the missing link in these hard-to-heal wounds.

Preventing pressure injuries has always been a challenge, not just for the caregivers, but also for the health care system as a whole.

The cost of caring for non-healing, chronic wounds in the United States has been estimated at a staggering $50 billion per year, 10 times more than the budget of the World Health Organization.

Surgical intervention remains one of the key pillars of treatment in health care.

High bacterial loads and biofilm impede wound healing and must be removed but are challenging to detect at the point-of-care.